Czechia· CZ-0027419

CETROTIDE

A cetrorelix product containing cetrorelix acetate, registered in Czechia by Merck Europe B.V., Amsterdam. The same ATC class is registered in 15 of our 19 countries.

ATC H01CC02

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedCETROTIDEATCH01CC02REGISTER NO.CZ-0027419PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Cetrorelix is registered in 15 of 19 countries.

Countries holding a registration under ATC H01CC02 (cetrorelix), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 9 of them publish a price we can compare per daily dose

Cetrorelix · ATC H01CC02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cetrorelix costs, country by country.

Normalised to the WHO defined daily dose (0.25 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Cetrorelix · price per daily dose (0.25 mg)

USD · FX 28 Sept 2026

  • ES Spain$40.95
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
CETRORELIX ACETATE
Manufacturer
Merck Europe B.V., Amsterdam
Country
Czechia (CZ)
ATC code
H01CC02
ATC class
Cetrorelix
Defined daily dose
0.25 mg, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0027419
    1+1X1ML ISP+2J
    CZK 893.08

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cetrorelix in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cetrorelix products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Belgium · Ceziboe
  • Germany · Ceziboe
  • Spain · Ceziboe Sun
  • France · Ceziboe
  • United Kingdom (Northern Ireland) · Ceziboe
  • Greece · Ceziboe
  • Hungary · Ceziboe
  • Ireland · Ceziboe
  • Iceland · Cetrotide
  • Italy · Ceziboe
  • Liechtenstein · Cetrotide
  • Netherlands · Ceziboe
  • Norway · Cetrotide

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/76b10545-d97e-41e4-a61f-51c5a14eda95
GET /v1/drugs/76b10545-d97e-41e4-a61f-51c5a14eda95?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ PSO LQF",
  "source": "sukl",
  "strength": "0,25MG",
  "pack_size": "1+1X1ML ISP+2J",
  "substance": "CETRORELIX ACETATE",
  "cz_kod_sukl": "0027419",
  "product_type": "CH",
  "substance_codes": "15701",
  "registration_state": "R",
  "registration_number": "EU/1/99/100/001"
}

See everything about cetrorelix.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.